Browse > Article

Effect of Excipients on the Stability and Transport of Recombinant Human Epidermal Growth Factor (rhEGF) across Caco-2 Cell Monolayers  

Kim, In-Wha (Research Institute Development of Pharmaceutical Resources, Chungbuk National University)
Yoo, Ho-Jung (Department of Pharmaceutics, College of Pharmacy, Seoul National University)
Song, Im-Sook (Department of Pharmaceutics, College of Pharmacy, Seoul National University)
Chung, Youn-Bok (Research Institute Development of Pharmaceutical Resources, Chungbuk National University)
Moon, Dong-Cheul (Research Institute Development of Pharmaceutical Resources, Chungbuk National University)
Chung, Suk-Jae (Department of Pharmaceutics, College of Pharmacy, Seoul National University)
Shim, Chang-Koo (Department of Pharmaceutics, College of Pharmacy, Seoul National University)
Publication Information
Archives of Pharmacal Research / v.26, no.4, 2003 , pp. 330-337 More about this Journal
Abstract
The effect of sixteen excipients on the transport of recombinant human epidermal growth factor (rhEGF) across Caco-2 cell monolayers was examined at $37^{\circ}C$. The apparent apical to basolateral (A-B) permeability ($P_{app}$) of 30 $\mu$ M rhEGF was $8.15\times 10^{-7}$ cm/sec, indicative of a poor level of absorption in the GI tract. The Papp was 1.7- and 6.3-fold greater than the $P_{app}$ in the basolateral to apical (B-A) direction and the A-B permeability of mannitol, respectively, and decreased dramatically to a negligible level at $4^{\circ}C$, consistent with a receptor mediated transcytosis of rhEGF. The stability of rhEGF was very poor, undergoing more than 85% degradation in 2 h in the transport medium at $37^{\circ}C$. A significant increase in the $P_{app}$ could be achieved by the addition of certain excipients, as exemplified by 23, 21, 20 and 16-fold increases, in the presence of sodium taurochenodeoxycholate (NaTCDC), sodium taurodeoxycholate (NaTDC), sodium glycodeoxycholate (NaGDC) and sodium laurylsulfate (SLS) (all at a concentration of 1 % w/v), respectively. A significant increase in stability could also be achieved by the addition of some of the excipients, as represented by 1 % SLS, which nearly completely stabilized the rhEGF. Unfortunately, however, an increase in the $P_{app}$ of rhEGF could not be achieved without a simultaneous and extensive decrease in the integrity of the cell membranes. Thus, more efficient excipients, that specifically enhance the permeation of rhEGF and do not alter the membrane integrity, should be pursued in order to safely enhance the permeation of rhEGF.
Keywords
rhEGF; Caco-2 cell monolayer; Absorption enhancers; Stabilizing agents;
Citations & Related Records

Times Cited By Web Of Science : 3  (Related Records In Web of Science)
Times Cited By SCOPUS : 4
연도 인용수 순위
1 Anderberg, E. K., Nystrom, C., and Artursson, P., Epithelial transport of drugs in cell culture. VII: Effect of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells. J. Pharm. Sci., 81, 879-887 (1992)   DOI   PUBMED
2 Costantino, H., Carrasquillo, K. G., Cordero, R. C., Mumenthaler, M., Hsu, C. C., and Griebenow, K., Effect of excipients on the stability and structure of lyophilized recombinant human growth hormone. J. Pharm. Sci., 87, 1412-1419 (1998)   DOI   PUBMED
3 Han, K., Choi, M. S., and Chung, Y. B., Site-specific degradation and transport of recombinant human epidermal growth factor (rhEGF) in the rat gastrointestinal mucosa. Int. J. Pharm., 168, 189-197 (1998)   DOI   ScienceOn
4 Lillienau, J., Schteingart, C. D., and Hofmann, A. F., Physicochemical and physiological of cholylsarcosine, a potential replacement detergent for bile acid deficiency states in the small intestine. J. Clin. Invest., 89, 420-431 (1992)   DOI   PUBMED
5 Merkus, W. H. M. M., Verhoef, J. C., Romeijin, S. G., and Schipper, N. G. M., Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats. Pharm. Res., 8, 588-592 (1991)   DOI   ScienceOn
6 Okada, H., Yamazaki, I., Ogawa, Y., Hirai, S., Yashiki, T., and Mima, H., Vaginal absorption of a potent luteinizing hormone releasing hormone analog (leuprolide) in rats I: absorption by various routes and absorption enhancement. J. Pharm. Sci., 71, 1367-1371 (1982)   DOI   PUBMED
7 Palomino, A., Hernandez-Bernal, F., Haedo, W., Franco, S., Mas, J. A., Fernandez, J. A., Soto, G., Alonso, A., Gonzalez, T., and Lopez-Saura, P., A multicenter, randomized, doubleblind clinical trial examining the effect of oral human recombinant epidermal growth factor on the healing of duodenal ulcers. Scand. J. Gastroenterol., 35, 1016-1022 (2000)   DOI   ScienceOn
8 Tarnawski, A., Stachura, J., Krause, W. J., Douglass, T. G., and Gergely, H., Quality of gastric ulcer healing: A new, emerging concept. J. Clin. Gastrienterol., 13 (Suppl 1), S42-S47 (1991)   DOI
9 Haeberlin, B., Gengenbacher, T., Meinzer, A., and Fricker, G., Cyclodextrins-Useful excipients for oral peptide administration. Int. J. Pharm., 137, 103-110 (1996)   DOI   ScienceOn
10 Murakami, T, Kishimoto, M., Kawakita, M., and Kisaki, M., Enhanced rectal and nasal absorption of human epidermal growth factor by combined use of the absorption promotor and the synthetic polymer in rats. Eur. J. Drug. Metab. Pharmacokinet., 3, 125-131 (1991)   DOI
11 Knipp, G. T., Ho, N. F. H., Barsuhn, C. L., and Borchardt, R. T., Paracellular diffusion in Caco-2 cell monolayers: Effect of perturbation on the transport of hydrophilic compounds that vary in charge and size. J. Pharm. Sci., 86, 1105-1110 (1997)   DOI   ScienceOn
12 Pade, V. and Stavchansky, S., Estimation of the relative contribution of transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model. Pharm. Res., 14, 1210-1215 (1997)   DOI   ScienceOn
13 Murakami, T., Kawakita, H., Kishimoto, M., Higashi, Y., Amagase, H., Hayashi, T., Nojima, N., Fuwa, T., and Yata, N., Intravenous and subcutaneous pharmacokinetics and rectal bioavailability of human epidermal growth factor in the presence of absorption promotor in rats. Int. J. Pharm., 46, 9-17 (1988)   DOI   ScienceOn
14 Anderberg, E. K. and Artursson, P., Epithelial transport of drugs in cell culture. VIII: Effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells. J. Pharm. Sci., 82, 392-398 (1993)   DOI   ScienceOn
15 Hidalgo, I. J., Kato, A., and Borchardt, R. T., Binding of epidermal growth factor by human colon carcinoma cell (Caco-2) monolayers. Biochem. Biophys. Res. Commun., 160, 317-324 (1989a)   DOI   ScienceOn
16 Scipper, N. G. M., Romeijn, S. G., Verhoef, J. C., and Merkus, F. W. H. M., Nasal insulin delivery with dimethyl-b-cyclodextrin as an absorption enhancer in rabbits: Powder more effective than liquid formulations. Pharm. Res., 10, 682-686 (1993)   DOI   ScienceOn
17 Artursson, P. and Karlsson, J., Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun., 175, 880-885 (1991)   DOI   ScienceOn
18 Murakami, T., Misaki, M., Kojima, Y., Yamada, M., Yuki, M., Higashi, Y., Amagase, H., Fuwa, T., and Yata, N., Effect of absorption promoters on subcutaneous absorption of human epidermal growth factor in rats. J. Pharm. Sci., 82, 236-239 (1993)   DOI   PUBMED
19 Carpenter, G. and Cohen, S., Epidermal growth factor (EGF). Ann. Rev. Biochem., 48, 193-216 (1979)   DOI   ScienceOn
20 Michael, S., Thole, M., Dillmann, R., Fahr, A., Drewe, J., and Fricker, G., Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine. Eur. J. Pharm. Sci., 10, 133-140 (2000)   DOI   ScienceOn
21 Tong, W. M., Ellinger, A., Shieinin, Y., and Cross, H. S., Epidermal growth factor receptor expression in primary cultured human colorectal carcinoma cells. Br. J. Cancer, 77, 1792-1798 (1998)   DOI   PUBMED   ScienceOn
22 Lindmark, T., Nikkila, T., and Artursson, P., Mechanism of absorption enhancement by medium chain fatty acids in intestinal epithelium Caco-2 cell monolayers. J. Pharm. Exp. Ther., 275, 958-964 (1995)
23 Sai, Y., Kajita, M., Tamai, I., Wakama, J., Wakamiya, T., and Tsuji, A., Adsorptive-mediated transcytosis of a basic peptide, 001-C8 in Caco-2 cells. Pharm. Res., 15, 1305-1309 (1998)   DOI   ScienceOn
24 Cromwell, R. M. E. M., Shahrokh, Z., Villagran, J., Nguyen, N. Y., Wellton, M., Nguyen, T. H., and Mrsny, J., Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue. J. Pharm. Sci., 85, 165-169 (1996)   DOI   PUBMED
25 Konturek, P. C., Konturek, S. J., Brzozowski, T., and Ernst, H., Epidermal growth factor and transforming growth factoralpha: Role in the protection and healing of gastric mucosal lesions. Eur. J. Gastroenterol. Hepatol., 7, 933-937 (1995)   DOI   ScienceOn
26 Shen, W. H. and Xu, R. J., Stability and distribution of orally administered epidermal growth factor in neonatal pigs. Life Sci., 63, 809-820 (1998)   DOI   ScienceOn
27 Son, K. and Kwon, C., Stabilization of human epidermanl growth factor (rEGF) in aqueous formulation. Pharm. Res., 12, 451-454 (1995)   DOI   ScienceOn
28 Hidalgo, I. J., Raub, T. J., and Borchardt, R. T., Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterol., 96, 736-749 (1989b)
29 Sakai, M., Imai, T., Ohtake, H., Azuma, H., and Otagiri, M., Effects of absorption enhancers on the transport on model compounds in Caco-2 cell monolayers: Assessment by confocal laser scanning microscopy. J. Pharm. Sci., 7, 779-785 (1997)
30 Augustijns, P. F., Bradshaw, T. P., Gan, L. S. L., Hendren, R. W., and Tharkler, D. R., Evidence for a polarized efflux system in Caco-2 cells capable of modulating cyclosporin A transport. Biochem. Biophys. Res. Commun., 197, 360-365 (1993)   DOI   PUBMED   ScienceOn